Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).
These guidelines update previous guidance published in 2005. They have been revised by a group who are members of the UK and Ireland Neuroendocrine Tumour Society with endorsement from the clinical committees of the British Society of Gastroenterology, the Society for Endocrinology, the Association...
Main Authors: | Ramage, J, Ahmed, A, Ardill, J, Bax, N, Breen, D, Caplin, M, Corrie, P, Davar, J, Davies, A, Lewington, V, Meyer, T, Newell-Price, J, Poston, G, Reed, N, Rockall, A, Steward, W, Thakker, R, Toubanakis, C, Valle, J, Verbeke, C, Grossman, AB |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2012
|
Similar Items
-
Gastroenteropancreatic neuroendocrine tumours.
by: Modlin, I, et al.
Published: (2008) -
Genetics of neuroendocrine and carcinoid tumours.
by: Leotlela, P, et al.
Published: (2003) -
An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology.
by: Chetty, R
Published: (2008) -
Capecitabine and streptozocin ± cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial
by: Meyer, T, et al.
Published: (2016) -
Calcium Sensing receptor expression is downregulated in gastroenteropancreatic neuroendocrine tumours via epigenetic mechanisms
by: English, KA, et al.
Published: (2024)